BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32511695)

  • 1. Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective.
    Bar-Yoseph H; Carasso S; Shklar S; Korytny A; Even Dar R; Daoud H; Nassar R; Maharshak N; Hussein K; Geffen Y; Chowers Y; Geva-Zatorsky N; Paul M
    Clin Infect Dis; 2021 Jul; 73(1):e166-e175. PubMed ID: 32511695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.
    Huttner BD; de Lastours V; Wassenberg M; Maharshak N; Mauris A; Galperine T; Zanichelli V; Kapel N; Bellanger A; Olearo F; Duval X; Armand-Lefevre L; Carmeli Y; Bonten M; Fantin B; Harbarth S;
    Clin Microbiol Infect; 2019 Jul; 25(7):830-838. PubMed ID: 30616014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial.
    Leo S; Lazarevic V; Girard M; Gaïa N; Schrenzel J; de Lastours V; Fantin B; Bonten M; Carmeli Y; Rondinaud E; Harbarth S; Huttner BD
    Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32585945
    [No Abstract]   [Full Text] [Related]  

  • 4. Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities.
    Saïdani N; Lagier JC; Cassir N; Million M; Baron S; Dubourg G; Eldin C; Kerbaj J; Valles C; Raoult D; Brouqui P
    Int J Antimicrob Agents; 2019 Apr; 53(4):355-361. PubMed ID: 30472293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms.
    Hyun J; Lee SK; Cheon JH; Yong DE; Koh H; Kang YK; Kim MH; Sohn Y; Cho Y; Baek YJ; Kim JH; Ahn JY; Jeong SJ; Yeom JS; Choi JY
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):20. PubMed ID: 35093183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.
    Dinh A; Fessi H; Duran C; Batista R; Michelon H; Bouchand F; Lepeule R; Vittecoq D; Escaut L; Sobhani I; Lawrence C; Chast F; Ronco P; Davido B
    J Hosp Infect; 2018 Aug; 99(4):481-486. PubMed ID: 29477634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage.
    Catho G; Huttner BD
    Expert Rev Anti Infect Ther; 2019 Aug; 17(8):557-569. PubMed ID: 31313610
    [No Abstract]   [Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction.
    Seong H; Lee SK; Cheon JH; Yong DE; Koh H; Kang YK; Jeong WY; Lee WJ; Sohn Y; Cho Y; Hyun JH; Baek YJ; Kim MH; Kim JH; Ahn JY; Ku NS; Jeong SJ; Yeom JS; Cho MS; Lee JH; Kim BY; Choi JY
    J Infect; 2020 Nov; 81(5):719-725. PubMed ID: 32920061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation in the intestinal decolonization of carbapenamase-producing enterobacteriaceae.
    Silva JC; Ponte A; Mota M; Pinho R; Vieira N; Oliveira R; Mota-Carvalho N; Gomes AC; Afecto E; Carvalho J
    Rev Esp Enferm Dig; 2020 Dec; 112(12):925-928. PubMed ID: 33118360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis.
    Chen Q; Fan Y; Zhang B; Yan C; Chen Z; Wang L; Hu Y; Huang Q; Su J; Ren J; Xu H
    Front Cell Infect Microbiol; 2022; 12():1086885. PubMed ID: 36683707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
    Su F; Luo Y; Yu J; Shi J; Zhao Y; Yan M; Huang H; Tan Y
    Eur J Med Res; 2021 Apr; 26(1):37. PubMed ID: 33910622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review.
    Macareño-Castro J; Solano-Salazar A; Dong LT; Mohiuddin M; Espinoza JL
    J Infect; 2022 Jun; 84(6):749-759. PubMed ID: 35461908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Evaluation of Gut Bacteriomes and Viromes after Fecal Microbiota Transplantation for Eradication of Carbapenem-Resistant
    Liu Q; Zuo T; Lu W; Yeoh YK; Su Q; Xu Z; Tang W; Yang K; Zhang F; Lau LHS; Lui RNS; Chin ML; Wong R; Cheung CP; Zhu W; Chan PKS; Chan FKL; Lui GC; Ng SC
    mSystems; 2022 Jun; 7(3):e0151021. PubMed ID: 35642928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study.
    Singh R; de Groot PF; Geerlings SE; Hodiamont CJ; Belzer C; Berge IJMT; de Vos WM; Bemelman FJ; Nieuwdorp M
    BMC Res Notes; 2018 Mar; 11(1):190. PubMed ID: 29566738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond
    Yoon YK; Suh JW; Kang EJ; Kim JY
    Ann Med; 2019; 51(7-8):379-389. PubMed ID: 31468999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study.
    Giannella M; Bartoletti M; Campoli C; Rinaldi M; Coladonato S; Pascale R; Tedeschi S; Ambretti S; Cristini F; Tumietto F; Siniscalchi A; Bertuzzo V; Morelli MC; Cescon M; Pinna AD; Lewis R; Viale P
    Clin Microbiol Infect; 2019 Dec; 25(12):1525-1531. PubMed ID: 31039445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India.
    Mittal G; Gaind R; Kumar D; Kaushik G; Gupta KB; Verma PK; Deb M
    BMC Microbiol; 2016 Jul; 16(1):138. PubMed ID: 27392139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.
    Errico G; Gagliotti C; Monaco M; Masiero L; Gaibani P; Ambretti S; Landini MP; D'Arezzo S; Di Caro A; Parisi SG; Palù G; Vespasiano F; Morsillo F; Moro ML; Procaccio F; Ricci A; Grossi PA; Pantosti A; Nanni Costa A;
    Clin Microbiol Infect; 2019 Feb; 25(2):203-209. PubMed ID: 29800674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.